Management and operation of a biocontainment laboratory for safe research
Official title: Facility Management, Maintenance and Operations Core
Funded at University of Chicago · NIH-10910205 · Data updated 2026-11-12
This study looks at how the Howard T Ricketts Regional Biocontainment Laboratory keeps researchers safe while they study harmful germs, like the coronavirus, so they can focus on their important work without worrying about safety.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project start | August 18, 2023 |
| Project end | July 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $1,081,907 |
| NIH project number | 5UC7AI180312-02 |
| Project ID | NIH-10910205 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include researchers and scientists working on infectious diseases, particularly those studying COVID-19 and other high-risk pathogens.
✕Less likely to help
Patients who are not involved in research or do not have a direct interest in infectious disease studies may not receive any benefit from this research.
What this research studies
This research focuses on the management and operations of the Howard T Ricketts Regional Biocontainment Laboratory (HTRL), which is designed to safely conduct research on dangerous pathogens, including the novel coronavirus. The facility ensures continuous containment through rigorous decontamination, maintenance, and compliance with biosafety regulations. A collaborative team of experts oversees the laboratory's operations, allowing researchers to concentrate on their scientific objectives while maintaining high safety standards. This core facility supports various research programs by providing a secure environment for experimentation.
Why it matters
Potential benefit: If successful, this research could enhance the safety and effectiveness of studies on infectious diseases, ultimately contributing to better public health outcomes.
How similar studies have gone: Other research facilities have successfully implemented similar management and operational strategies to enhance biosafety and containment, indicating a proven approach.
Where this research is happening
-
University of Chicago
Chicago, United States Active
Researchers
- Principal investigator: Langan, George Parsons — University of Chicago
- Study coordinator: Langan, George Parsons
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.